Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lifecore Biomedical, Inc. (LFCR:NASDAQ), powered by AI.
Lifecore Biomedical, Inc. is currently trading at $5.64. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lifecore Biomedical, Inc. on Alpha Lenz.
Lifecore Biomedical, Inc.'s P/E ratio is -5.1.
“Lifecore Biomedical, Inc. has a P/E of -5.1. Compare its valuation with peers.”
Ask for details →Lifecore Biomedical Inc. is a prominent entity in the biotechnology sector, primarily engaged in the manufacture and development of high-quality biomedical products. The company specializes in the production of hyaluronan and other polysaccharide-based products for medical applications. These biomaterials are crucial in various medical fields, including ophthalmology, orthopedics, and general surgery, thanks to their biocompatibility and multifunctional characteristics. Lifecore Biomedical Inc.'s expertise in manufacturing and formulation is underscored by its integration with the pharmaceutical and health industries, where its products are utilized in drug delivery systems and surgical applications. Established with a commitment to quality and innovation, the company plays a significant role in advancing medical technology and improving patient outcomes globally. Its presence in the market underscores the critical interface between leading-edge biotechnology and practical health applications, making it a key player in the advancement of medical treatments and technologies.
“Lifecore Biomedical, Inc. has a P/E of -5.1. Compare its valuation with peers.”
Ask for details →Lifecore Biomedical, Inc. (ticker: LFCR) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 406 employees. Market cap is $196M.
The current price is $5.64 with a P/E ratio of -5.07x and P/B of 146.99x.